Oral THC with a small amount of CBD may be effective in reducing a host of negative symptoms associated with Alzheimer disease, according to a study published in the recent issue of the journal Clinical Therapeutics.
As noted by the study’s abstract, ten million new cases of dementia are recorded annually worldwide, with agitation and idiopathic weight loss being the most common symptoms. Although several pharmacological therapies have emerged in recent years, “the clinical use of cannabis extracts in older patients with AD is constantly growing.”
This retrospective, analytical, observational, spontaneous trial “aimed to enhance the clinical action of THC: CBD cannabis extract administration in AD patients with severe symptoms such as agitation, weight loss, cognitive impairment, and sleep disturbance.”
Continue reading